Literature DB >> 15743753

The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens.

Schuyler O Sanderson1, Thomas C Smyrk.   

Abstract

Nonalcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH) and typically are indistinguishable, histologically. The diagnosis relies on reporting of alcohol consumption. The metabolic syndrome involving insulin resistance is associated with nonalcoholic fatty liver disease (NAFLD). Protein tyrosine phosphatase 1B (PTP1B) negatively regulates the insulin receptor (IR). Increased PTP1B expression is seen in obesity and possibly is responsible for the insulin resistance seen in the metabolic syndrome. The study objective was to determine whether biopsy specimens with steatohepatitis could be classified accurately as alcoholic or nonalcoholic by immunohistochemical stains. We selected 241 cases of steatohepatitis, comprising 53 and 188 cases of alcoholic and NAFLD, respectively. Specimens were stained with PTP1B and IR (b subunit) and classified as NASH or ASH. The staining pattern predicted 60 cases of ASH and 181 cases of NASH. Results correlated with clinical diagnoses in 70% and 88% of ASH and NASH cases, respectively (odds ratio, 16.6; 95% confidence interval, 8.2-35.4).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743753     DOI: 10.1309/1PX2-LMPQ-UH1E-E12U

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

Review 1.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

3.  Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Authors:  Winston Dunn; Paul Angulo; Schuyler Sanderson; Laith H Jamil; Linda Stadheim; Charles Rosen; Michael Malinchoc; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2006-08-10       Impact factor: 22.682

4.  Hepatic PTP1B Deficiency: The Promise of a Treatment for Metabolic Syndrome?

Authors:  Kendra K Bence
Journal:  J Clin Metab Diabetes       Date:  2010-05

Review 5.  Selenium and diabetes--evidence from animal studies.

Authors:  Jun Zhou; Kaixun Huang; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2013-07-16       Impact factor: 7.376

6.  Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?

Authors:  Lili Kazemi-Shirazi; Moema Pinheiro Veloso; Florian Frommlet; Petra Steindl-Munda; Fritz Wrba; Sonja Zehetmayer; Claudia Marsik; Peter Ferenci
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

7.  Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspring.

Authors:  M A Hyatt; D S Gardner; S Sebert; V Wilson; N Davidson; Y Nigmatullina; L L Y Chan; H Budge; M E Symonds
Journal:  Reproduction       Date:  2010-11-02       Impact factor: 3.906

8.  Inhibition of Protein-tyrosine Phosphatase PTP1B and LMPTP Promotes Palmitate/Oleate-challenged HepG2 Cell Survival by Reducing Lipoapoptosis, Improving Mitochondrial Dynamics and Mitigating Oxidative and Endoplasmic Reticulum Stress.

Authors:  Lynda Bourebaba; Jacek Łyczko; Michalina Alicka; Nabila Bourebaba; Antoni Szumny; Andrzej M Fal; Krzysztof Marycz
Journal:  J Clin Med       Date:  2020-05-01       Impact factor: 4.241

9.  Protein tyrosine phosphatase 1B modulates GSK3β/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity.

Authors:  M A Mobasher; A González-Rodriguez; B Santamaría; S Ramos; M Á Martín; L Goya; P Rada; L Letzig; L P James; A Cuadrado; J Martín-Pérez; K J Simpson; J Muntané; A M Valverde
Journal:  Cell Death Dis       Date:  2013-05-09       Impact factor: 8.469

10.  Harnessing insulin- and leptin-induced oxidation of PTP1B for therapeutic development.

Authors:  Navasona Krishnan; Christopher A Bonham; Ioana A Rus; Om Kumar Shrestha; Carla M Gauss; Aftabul Haque; Ante Tocilj; Leemor Joshua-Tor; Nicholas K Tonks
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.